• About The NAS
  • Mission
  • History
  • Organization
  • Leadership and Governance
  • Code of Conduct
  • NAS Strategic Plan
  • Policy on Discrimination, Harassment, and Bullying
  • Membership
  • Policy Studies and Reports
  • Events
  • Locations
  • Careers
  • Giving to NAS
  • Contact Us
• |
• Membership
  • Overview
  • Member Directory
• |
• Programs
  • Awards
  • Cultural Programs
  • Distinctive Voices
  • Human Gene Editing Initiative
  • Kavli Frontiers of Science
  • LabX
  • US-UK Scientific Forum
  • US-Israel Blavatnik Scientific Forum
  • From Research to Reward
  • The Science Behind It
  • Science & Entertainment Exchange
  • Committee on International Security and Arms Control
  • Committee on Human Rights
  • Committee on Science, Engineering, Medicine, and Public Policy
  • Committee on Women in Science, Engineering, and Medicine
  • Government-University-
    Industry Research Roundtable
  • NAS Colloquia (inactive)
  • National Academies Keck
    Futures Initiative (inactive)
• |
• Publications
  • Proceedings of the National Academy of Sciences
  • PNAS Nexus
  • National Academies Press
  • Biographical Memoirs
  • Issues in Science
    and Technology
  • Transparency in Author Contributions
  • Beyond Discovery (inactive)
• |
• Member Login

www.nasonline.org  |  News & Multimedia  |  Video Gallery  |  151st Annual Meeting |   Jeffrey Settleman

• News
• Social Media
  • #PhotosWithAlbert

Symposium—Cancer: From Basic Science to New Treatments, Prevention, and Back

Personalizing Cancer Treatment with Targeted Drugs

Jeffrey Settleman
Senior Director, Discovery Oncology, Genentech, Inc.
April 28, 2014

Related Links

Symposium on Cancer | 151st NAS Annual Meeting Highlights